Selection and validation of chemotherapy beneficiaries among elderly nasopharyngeal carcinoma (npc) patients treated with intensity-modulated radiation therapy (imrt): a large real-world study

HIGHLIGHTS

• who: Yan-Ling Wu from the Department of Radiation Oncology, State Key Laboratory of Oncology Medicine, Sun Yat-Sen University Cancer Center, Dongfeng Road East, Guangzhou, People`s Republic of China have published the research: Selection and validation of chemotherapy beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiation therapy (IMRT): a large real-world study, in the Journal: (JOURNAL)
• what: The study showed that the OS benefit for the poor-prognosis group was mainly reflected in the IC + CCRT and CCRT regimens but not in the IC + RT regimens (Fig 2 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.